Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance (Q34547868)

2 August 2017

1 reference

title

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance (English)

1 reference

2 August 2017

antibiotic resistance

1 reference

inferred from title

Staphylococcus aureus

1 reference

1 reference

K Hiramatsu

1

1 reference

2 August 2017

1 October 2001

1 reference

Lancet Infectious Diseases

2 August 2017

1 reference

2 August 2017

1

1 reference

2 August 2017

147-155

1 reference

2 August 2017

3

1 reference

“Celbenin” - resistant Staphylococci

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

The changing epidemiology of Staphylococcus aureus?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Vancomycin-intermediate Staphylococcus aureus in Korea.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Vancomycin resistance in staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Penicillin-binding proteins of beta-lactam-resistant strains of Staphylococcus aureus. Effect of growth conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Whole genome sequencing of meticillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Eagle-type methicillin resistance: new phenotype of high methicillin resistance under mec regulator gene control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

[Combination effect of teicoplanin and various antibiotics against hetero-VRSA and VRSA]

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

In-vitro activity of DU-6859a against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibilities to vancomycin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900091-3

7 January 2021

10.1016/S1473-3099(01)00091-3

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11871491